Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 286368, 10 pages
http://dx.doi.org/10.1155/2013/286368
Research Article

FOXP3+ T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNF Agents

1Department of Internal Medicine, Inflammatory Bowel Disease Unit, Complesso Integrato Columbus, Catholic University, Largo Gemelli 8, 00168 Rome, Italy
2Department of Gynaecology, Catholic University, Rome, Italy
3Inflammatory Bowel Disease Unit, IRCCS Clinical Institute Humanitas, Rozzano, Milano, Italy
4Department of Paediatric Haematology/Oncology, IRCCS Bambin Gesù Children’s Hospital, Rome, Italy

Received 30 April 2013; Accepted 8 July 2013

Academic Editor: Silvia Gregori

Copyright © 2013 Luisa Guidi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [14 citations]

The following is the list of published articles that have cited the current article.

  • Oriol Juanola, José F. Such, Rubén Francés, Alba Moratalla, Ana Gutiérrez, Laura Sempere, Pedro Zapater, Paula Giménez, Isabel Almenta, Gloria Peiró, and José M. González-Navajas, “Anti-TNF-alpha loss of response is associated with a decreased percentage of FoxP3+ T cells and a variant NOD2 genotype in patients with Crohn’s disease,” Journal of Gastroenterology, vol. 50, no. 7, pp. 758–768, 2014. View at Publisher · View at Google Scholar
  • Anne M. Pesenacker, Raewyn Broady, and Megan K. Levings, “Control of tissue-localized immune responses by human regulatory T cells,” European Journal of Immunology, 2014. View at Publisher · View at Google Scholar
  • Yanbiao Chu, Xiaoying Xiangli, and Wei Xiao, “Regulatory T cells protect against hypoxia-induced pulmonary arterial hypertension in mice,” Molecular Medicine Reports, 2014. View at Publisher · View at Google Scholar
  • C. Felice, A. Lewis, A. Armuzzi, J. O. Lindsay, and A. Silver, “Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases,” Alimentary Pharmacology & Therapeutics, 2014. View at Publisher · View at Google Scholar
  • Maria Grazia Petrillo, Simona Ronchetti, Erika Ricci, Alessia Alunno, Roberto Gerli, Giuseppe Nocentini, and Carlo Riccardi, “GITR+ regulatory T cells in the treatment of autoimmune diseases,” Autoimmunity Reviews, 2014. View at Publisher · View at Google Scholar
  • Charlotte R. Grant, Rodrigo Liberal, Giorgina Mieli-Vergani, Diego Vergani, and Maria Serena Longhi, “Regulatory T-cells in autoimmune diseases: Challenges, controversies and - yet - unanswered questions,” Autoimmunity Reviews, 2014. View at Publisher · View at Google Scholar
  • K.T. Amber, R. Bloom, U. Mrowietz, and M. Hertl, “TNF-α: a treatment target or cause of sarcoidosis?,” Journal of the European Academy of Dermatology and Venereology, 2015. View at Publisher · View at Google Scholar
  • Mousa Mohammadnia-Afrouzi, Ahmad Zavaran Hosseini, Ali Khalili, Saeid Abediankenari, Vahid Hosseini, and Iradj Maleki, “ Decrease of CD4 + CD25 + CD127 low FoxP3 + regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients ,” Autoimmunity, vol. 48, no. 8, pp. 556–561, 2015. View at Publisher · View at Google Scholar
  • Giovanni Cammarota, Gianluca Ianiro, Rossella Cianci, Stefano Bibbò, Antonio Gasbarrini, and Diego Currò, “The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy,” Pharmacology & Therapeutics, 2015. View at Publisher · View at Google Scholar
  • Richard Wnek, Michelle Tseng, and Dianna Wu, “Current Flow Cytometry Methods for the Clinical Development of Immunomodulatory Biologics,” Translating Molecular Biomarkers into Clinical Assays, vol. 37, pp. 141–151, 2016. View at Publisher · View at Google Scholar
  • Caroline Meyer Olesen, Mehmet Coskun, Laurent Peyrin-Biroulet, and Ole Haagen Nielsen, “Mechanisms behind efficacy of tnf inhibitors in inflammatory bowel diseases,” Pharmacology & Therapeutics, 2016. View at Publisher · View at Google Scholar
  • Krzysztof Linke, Janusz Witowski, and Piotr Eder, “Update on the mechanisms of action of anti-TNF-α antibodies and their clinical implications in inflammatory bowel disease,” Polskie Archiwum Medycyny Wewnetrznej, vol. 126, no. 10, pp. 772–780, 2016. View at Publisher · View at Google Scholar
  • Grainne Holleran, Loris Lopetuso, Valentina Petito, Cristina Graziani, Gianluca Ianiro, Deirdre McNamara, Antonio Gasbarrini, and Franco Scaldaferri, “The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease,” International Journal of Molecular Sciences, vol. 18, no. 10, pp. 2020, 2017. View at Publisher · View at Google Scholar
  • Malgorzata Bockowska, Anna Liberek, Katarzyna Sznurkowska, Maciej Zielinski, Barbara Kaminska, Agnieszka Szlagatys-Sidorkiewicz, Katarzyna Plata-Nazar, and Piotr Trzonkowski, “Peripheral regulatory T cells and anti-inflammatory cytokines in children with juvenile idiopathic arthritis,” Acta Biochimica Polonica, vol. 65, no. 1, pp. 119–123, 2018. View at Publisher · View at Google Scholar